Please wait a minute...
文章检索
预防医学  2022, Vol. 34 Issue (1): 83-86    DOI: 10.19485/j.cnki.issn2096-5087.2022.01.017
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2002—2017年黄浦区甲状腺癌发病趋势
裘凤黔, 杜娟, 纪云芳, 高淑娜, 何丽华, 凌青, 张艳
黄浦区疾病预防控制中心慢性病防治科,上海 200023
Trends in incidence of thyroid cancer in Huangpu District from 2002 to 2017
QIU Fengqian, DU Juan, JI Yunfang, GAO Shuna, HE Lihua, LING Qing, ZHANG Yan
Department of Chronic Diseases Control and Prevention, Huangpu Center for Disease Control and Prevention, Shanghai 200023, China
全文: PDF(866 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2002—2017年上海市黄浦区甲状腺癌发病率及其变化趋势,为甲状腺癌防制提供依据。方法 通过上海市疾病预防控制中心上海市肿瘤病例登记报告管理系统收集2002—2017年黄浦区甲状腺癌发病资料,计算不同年份、性别和年龄人群的粗发病率,标化发病率及其年度变化百分比(APC),分析甲状腺癌发病率的变化趋势。结果 2002—2017年黄浦区报告甲状腺癌新发病例2 854例,粗发病率为19.57/10万,标化发病率为13.47/10万,均呈上升趋势(P<0.05),APC值分别为18.15%和17.93%。男性甲状腺癌粗发病率为10.02/10万,标化发病率为7.06/10万,均呈上升趋势(P<0.05),APC值分别为19.58%和19.04%;女性甲状腺癌发粗发病率为28.90/10万,标化发病率为19.95/10万,均呈上升趋势(P<0.05),APC值分别为17.33%和16.99%。女性甲状腺癌粗发病率高于男性(P<0.05)。甲状腺癌年龄别粗发病率呈现2个高峰,分别为35~<40岁和60~<65岁,粗发病率分别为28.98/10万和33.36/10万。结论 2002—2017年黄浦区甲状腺癌发病率呈上升趋势,应重点关注女性和60~<65岁人群。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
裘凤黔
杜娟
纪云芳
高淑娜
何丽华
凌青
张艳
关键词 甲状腺癌发病率趋势年度变化百分比    
AbstractObjective To analyze the trends in incidence of thyroid cancer in Huangpu District, Shanghai from 2002 to 2017, so as to provide insights into the management of thyroid cancer. Methods The incidence of thyroid cancer in Shanghai from 2002 to 2017 was collected from the cancer registration system created by Shanghai Center for Disease Control and Prevention. The crude and standardized incidence of thyroid cancer were estimated by year, gender and age groups, and annual change percentage ( APC ) was calculated to analyze the trends in incidence of thyroid cancer. Results A total of 2 854 new cases of thyroid cancer were reported in Huangpu District from 2002 to 2017, and the crude and standardized incidence rates of thyroid cancer were 19.57/105 and 13.47/105, with APC of 18.15% and 17.93% ( P<0.05 ), respectively. The crude and standardized incidence rates of thyroid cancer were 10.02/105 and 7.06/105 in men, with APC of 19.58% and 19.04% ( P<0.05 ), and were 28.90/105 and 19.95/105 in women, with APC of 17.33% and 16.99% ( P<0.05 ), respectively. The crude incidence of thyroid cancer was higher in women than in men ( P<0.05 ). In addition, there were two peaks in the crude incidence of thyroid cancer in patients at age of 35 to 39 and 60 to 64 years, with crude incidence rates of 28.98/105 and 33.36/105, respectively. Conclusions The incidence of thyroid cancer appeared a tendency towards a rise in Huangpu District from 2002 to 2017, and much attention should be paid to females and patients aged 60 to 64 years.
Key wordsthyroid cancer    incidence    trend    annual percentage change
收稿日期: 2021-09-07      修回日期: 2021-11-08     
中图分类号:  R195.4  
基金资助:黄浦区卫生系统拔尖医学人才培养(2019BJ10)
作者简介: 裘凤黔,硕士,主治医师,主要从事慢性病防制工作
通信作者: 张艳,E-mail:smallbabyqq@163.com   
引用本文:   
裘凤黔, 杜娟, 纪云芳, 高淑娜, 何丽华, 凌青, 张艳. 2002—2017年黄浦区甲状腺癌发病趋势[J]. 预防医学, 2022, 34(1): 83-86.
QIU Fengqian, DU Juan, JI Yunfang, GAO Shuna, HE Lihua, LING Qing, ZHANG Yan. Trends in incidence of thyroid cancer in Huangpu District from 2002 to 2017. Preventive Medicine, 2022, 34(1): 83-86.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.01.017      或      https://www.zjyfyxzz.com/CN/Y2022/V34/I1/83
[1] BRAY F,FERLAY J,SOERJOMTARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] CHEN W Q,ZHENG R S,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[3] STEWART B,WILD C.World cancer report 2014[M].Lyon:IARC Press,2014:738-750.
[4] 鲍萍萍,吴春晓.上海市癌症流行现况和防治实践[J].上海预防医学,2020,32(11):955-962.
BAO P P,WU C X.Epidemiology,control and prevention of cancers in Shanghai[J].Shanghai J Prev Med,2020,32(11):955-962.
[5] 张洁,闫贻忠,王丹,等.2005—2014年中国肿瘤登记地区甲状腺癌发病的时间趋势分析[J].现代预防医学,2020,47(4):577-582.
ZHANG J,YAN Y Z,WANG D,et al.Time trend analysis of thyroid cancer in tumor registration of China from 2005 to 2014[J].Mod Prev Med,2020,47(4):577-582.
[6] 向芳,黄芳,张一英,等.2003—2013年上海市嘉定区甲状腺癌发病率变化趋势分析[J].中华预防医学杂志,2016,50(7):656-658.
XIANG F,HUANG F,ZHANG Y Y,et al.Trend in incidence of thyroid cancer in Jiading District of Shanghai,2003-2013[J].Chin J Prev Med,2016,50(7):656-658.
[7] 国家癌症中心.2018年中国肿瘤登记年报[M].北京:人民卫生出版社,2019:178-182.
National Cancer Center.China cancer registry annual report in 2018[M].Beijing:People's Medical Publishing House,2019:178-182.
[8] 李伟伟,周金意,董建梅,等.2015年江苏省甲状腺癌流行现状及2006—2015年趋势分析[J].实用肿瘤学杂志,2021,35(1):1-6.
LI W W,ZHOU J Y,DONG J M,et al.Epidemic status of thyroid cancer in Jiangsu province in 2015 and its trend analysis from 2006 to 2015[J].Pract Oncol J,2021,35(1):1-6.
[9] 郑文龙,张爽,沈成凤,等.天津市2010—2014年甲状腺癌流行特征及长期发病和死亡趋势分析[J].中国肿瘤,2018,27(9):670-674.
ZHENG W L,ZHANG S,SHEN C F,et al.Epidemiological characteristics and long-term trends of thyroid cancer in Tianjin[J].China Cancer,2018,27(9):670-674.
[10] 雷林,尚庆刚,刘秋耿,等.深圳市2001—2015年甲状腺癌发病现状和趋势分析[J].中国肿瘤,2019,28(7):504-508.
LEI L,SHANG Q G,LIU Q G,et al.Incidences and epidemiologic trends of thyroid cancer in Shenzhen,2001-2015[J].China Cancer,2019,28(7):504-508.
[11] 鲍萍萍,吴春晓,张敏璐,等.2015年上海市恶性肿瘤流行特征分析[J].中国癌症杂志,2019,29(2):81-99.
BAO P P,WU C X,ZHANG M L,et al.Report of cancer epidemiology in Shanghai,2015[J].Chin Oncol,2019,29(2):81-99.
[12] 滕卫平. 我国面临甲状腺癌“过度诊断”的挑战[J].中华内分泌代谢杂志,2016,32(7):531-532.
TENG W P.We are facing a challenge of “overdiagnosis” of the thyroid cancer[J].Chin J Endocrinol Metab,2016,32(7):531-532.
[13] BRAY F,FERLAY J,SOERJOMTARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[14] 谢林宏,黄恒艺,钟贤君.中国甲状腺癌发病趋势[J].世界最新医学信息文摘,2019,19(60):44-45.
XIE L H, HUANG H Y,ZHONG X J.Exploring the incidence trend of thyroid cancer in China[J].World Latest Med Inf,2019,19(60):44-45.
[15] 张璐,刘跃武.雌激素与甲状腺癌的关系[J].基础医学与临床,2010,30(7):782-784.
ZHANG L,LIU Y W.The relationship between estrogen and thyroid carcinoma[J].Basic Clin Med,2010,30(7):782-784.
[16] ZANE M,PARELLO C,PENNELLI G,et al.Estrogen and thyroidcancer is a stem affair:a preliminary study[J].Biomed Pharmacother,2017,85:399-411.
[17] 应可明,陈峥,燕归如,等.34例医务人员放射性甲状腺疾病临床特征分析[J].中国医药导刊,2018,20(5):265-270.
YING K M,CHEN Z,YAN G R,et al.Clinical characteristics analysis of 34 cases of radiation thyroid diseases of medical personnel[J].Chin J Med Guide,2018,20(5):265-270.
[18] 胡锦峰,傅容.杭州市城区居民甲状腺癌发病趋势分析[J].浙江预防医学,2016,28(3):244-246,255.
HU J F,FU R.An analysis on the trend of thyroid cancer incidence among urban residents in Hangzhou City[J].Zhejiang J Prev Med,2016,28(3):244-246,255.
[19] 陈万青,郑荣寿,张思维,等.2013年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2017,26(1):1-7.
CHEN W Q,ZHENG R S,ZHANG S W,et al.Report of cancer incidence and mortality in China,2013[J].China Cancer,2017,26(1):1-7.
[1] 韩亚蓉, 韩颖颖, 蔡波, 林玲. 2013—2022年南通市甲状腺癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(1): 20-25.
[2] 周凡, 王小红, 陈梦倩, 张小兰, 徐则林. 2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J]. 预防医学, 2026, 38(1): 26-30.
[3] 卢文海, 孔校杰, 宋丽霞, 卢春如, 于碧鲲, 谢延. SARIMA、Prophet与BSTS模型预测手足口病发病率的效果比较[J]. 预防医学, 2026, 38(1): 79-84.
[4] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[5] 李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
[6] 胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
[7] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[8] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[9] 朱颖, 郑添. 2013—2023年嘉善县居民期望寿命变化[J]. 预防医学, 2025, 37(6): 598-602.
[10] 董沙沙, 项云飞. 2014—2023年余姚市原发性肝癌死亡与疾病负担分析[J]. 预防医学, 2025, 37(6): 603-607.
[11] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[12] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[13] 姜欣跃, 刘洁楠, 高美伶, 王玉超, 洪伊娜 综述, 严剑波 审校. 电离辐射暴露与甲状腺癌的研究进展[J]. 预防医学, 2025, 37(5): 471-476,480.
[14] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[15] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed